Intrinsiqq
Exozymes Inc. logo

Exozymes Inc. Insider Trading

EXOZ

Compare
Last 12 months

Insiders bought 6K and sold 35K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Commercial Officer Damien Alan Perriman sold 19K on Oct 12, 12% of their stake, outside a plan.

Net open-market
−28K
1 buy · 2 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
1 / 2
executives and directors
Last open-market buy
Aug 2026
Aug 26, 2026

Get an email when EXOZ's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 12No plan
    Damien Alan Perriman
    Chief Commercial Officer · sold 3,729 at $5.21
    19K
    12% of stake
  • Aug 25 – 26
    Michael Heltzen
    Chief Executive Officer · bought 855 at avg $7.49
    6K
    6.6% of stake
  • Apr 8 – 9No plan
    Tyler Paz Korman
    Chief Scientific Officer · sold 1,500 at avg $10.29
    15K
    0.2% of stake
  • Jul 2, 2025
    Michael Heltzen
    Chief Executive Officer · bought 1,040 at $10.22
    11K
    11% of stake
  • Jan 16, 2025 – Jan 17, 2025
    Michael Heltzen
    Chief Executive Officer · bought 1,888 at avg $10.78
    20K
    95% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch EXOZ, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with EXOZ

CompareIntrinsic value
BCDABioCardia, Inc.
$0.79+2.60%26
INMBInmune Bio Inc.
$0.83-7.49%10
AIMAIM ImmunoTech Inc.
$0.11-4.50%25
ENZNViskase Holdings, Inc.
$4.35-1.14%0
SNTISenti Biosciences Inc.
$2.79-2.82%0
ALLOAllogene Therapeutics Inc.
$0.63-6.31%10
CADLCandel Therapeutics Inc.
$5.04-1.75%10
VIVSVivoSim Labs, Inc.
$0.26-10.34%10

Spot a number that looks wrong? Check it in EXOZ's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing EXOZ

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.